Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Kanady JD;Kanady JD; Dellinger MT; Munger SJ; Witte MH; Simon AM
  • Source:
    Developmental biology [Dev Biol] 2011 Jun 15; Vol. 354 (2), pp. 253-66. Date of Electronic Publication: 2011 Apr 16.
  • Publication Type:
    Journal Article; Research Support, N.I.H., Extramural
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Elsevier Country of Publication: United States NLM ID: 0372762 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-564X (Electronic) Linking ISSN: 00121606 NLM ISO Abbreviation: Dev Biol Subsets: MEDLINE
    • Publication Information:
      Publication: San Diego, CA : Elsevier
      Original Publication: New York.
    • Subject Terms:
    • Abstract:
      Intraluminal valves are required for the proper function of lymphatic collecting vessels and large lymphatic trunks like the thoracic duct. Despite recent progress in the study of lymphvasculogenesis and lymphangiogenesis, the molecular mechanisms controlling the morphogenesis of lymphatic valves remain poorly understood. Here, we report that gap junction proteins, or connexins (Cxs), are required for lymphatic valvulogenesis. Cx37 and Cx43 are expressed early in mouse lymphatic development in the jugular lymph sacs, and later in development these Cxs become enriched and differentially expressed by lymphatic endothelial cells on the upstream and downstream sides of the valves. Specific deficiencies of Cx37 and Cx43 alone or in combination result in defective valve formation in lymphatic collecting vessels, lymphedema, and chylothorax. We also show that Cx37 regulates jugular lymph sac size and that both Cx37 and Cx43 are required for normal thoracic duct development, including valve formation. Another Cx family member, Cx47, whose human analog is mutated in some families with lymphedema, is also highly enriched in a subset of endothelial cells in lymphatic valves. Mechanistically, we present data from Foxc2-/- embryos suggesting that Cx37 may be a target of regulation by Foxc2, a transcription factor that is mutated in human lymphedema-distichiasis syndrome. These results show that at least three Cxs are expressed in the developing lymphatic vasculature and, when defective, are associated with clinically manifest lymphatic disorders in mice and man.
      (Copyright © 2011 Elsevier Inc. All rights reserved.)
    • References:
      Trends Cell Biol. 2010 Feb;20(2):92-101. (PMID: 19944606)
      Pharmacol Ther. 2005 Feb;105(2):165-88. (PMID: 15670625)
      J Cell Biol. 2001 Jul 9;154(1):217-30. (PMID: 11449002)
      Anat Embryol (Berl). 1995 Sep;192(3):265-74. (PMID: 8651511)
      Am J Pathol. 2010 Oct;177(4):2124-33. (PMID: 20724596)
      Dev Biol. 2009 Mar 15;327(2):410-8. (PMID: 19150347)
      Histochem Cell Biol. 2004 Nov;122(5):477-83. (PMID: 15558296)
      J Neurosci. 2003 Jul 2;23(13):5963-73. (PMID: 12843301)
      Circ Res. 2001 Feb 16;88(3):333-9. (PMID: 11179202)
      Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3758-63. (PMID: 20130277)
      Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):606-11. (PMID: 17202268)
      Science. 1995 Mar 24;267(5205):1831-4. (PMID: 7892609)
      Antioxid Redox Signal. 2009 Feb;11(2):267-82. (PMID: 18834327)
      Curr Opin Cell Biol. 2004 Oct;16(5):507-12. (PMID: 15363800)
      Curr Biol. 1998 Feb 26;8(5):295-8. (PMID: 9501069)
      Cell Tissue Res. 2009 Jan;335(1):97-108. (PMID: 18648856)
      J Neurosci. 2003 Jun 1;23(11):4549-59. (PMID: 12805295)
      Development. 1997 Nov;124(22):4627-38. (PMID: 9409679)
      PLoS Biol. 2006 Oct;4(10):e315. (PMID: 16968134)
      Nat Genet. 2005 Oct;37(10):1072-81. (PMID: 16170315)
      Mol Cell Biol. 2000 Jul;20(14):5208-15. (PMID: 10866676)
      Blood. 2008 Sep 15;112(6):2318-26. (PMID: 18614759)
      Dev Biol. 2002 Nov 15;251(2):206-20. (PMID: 12435353)
      Dev Biol. 2005 Aug 15;284(2):479-98. (PMID: 16039638)
      Development. 2009 Sep;136(18):3185-93. (PMID: 19700622)
      Cell Commun Signal. 2009 Mar 12;7:4. (PMID: 19284610)
      Prenat Diagn. 2008 Nov;28(11):1057-63. (PMID: 18973153)
      Cell Mol Life Sci. 2007 Aug;64(15):1915-29. (PMID: 17458498)
      Genes Dev. 2005 Feb 1;19(3):397-410. (PMID: 15687262)
      Ann N Y Acad Sci. 2008;1131:82-8. (PMID: 18519961)
      Am J Hum Genet. 2010 Jun 11;86(6):943-8. (PMID: 20537300)
      Dev Cell. 2006 Sep;11(3):349-61. (PMID: 16950126)
      Circ Res. 1998 Sep 21;83(6):636-43. (PMID: 9742059)
      Biochim Biophys Acta. 2005 Jun 10;1711(2):208-14. (PMID: 15955305)
      Carcinogenesis. 2010 Nov;31(11):1922-31. (PMID: 20705954)
      Nat Med. 2004 Sep;10(9):974-81. (PMID: 15322537)
      J Histochem Cytochem. 1997 Apr;45(4):539-50. (PMID: 9111232)
      J Cell Sci. 2003 Jun 1;116(Pt 11):2223-36. (PMID: 12697838)
      Am J Hum Genet. 2000 Dec;67(6):1382-8. (PMID: 11078474)
      Development. 2010 Feb;137(3):363-72. (PMID: 20081185)
      Antioxid Redox Signal. 2009 Feb;11(2):251-66. (PMID: 18831678)
      Cell. 2010 Feb 19;140(4):460-76. (PMID: 20178740)
      Hum Mol Genet. 1998 Dec;7(13):2073-8. (PMID: 9817924)
      J Cell Sci. 2009 Jun 15;122(Pt 12):2043-54. (PMID: 19470583)
      Development. 2006 May;133(10):2063-73. (PMID: 16624854)
      Dev Cell. 2009 Aug;17(2):175-86. (PMID: 19686679)
      Development. 2000 Aug;127(16):3501-12. (PMID: 10903175)
      Ann N Y Acad Sci. 2008;1131:75-81. (PMID: 18519960)
      Am J Anat. 1971 Oct;132(2):207-17. (PMID: 4106988)
      Biochem J. 2006 Mar 15;394(Pt 3):527-43. (PMID: 16492141)
      Trends Cardiovasc Med. 2001 Aug;11(6):213-8. (PMID: 11673050)
      Blood. 2010 Jul 29;116(4):661-70. (PMID: 20363774)
      Lymphat Res Biol. 2009;7(2):87-96. (PMID: 19534632)
      J Cell Biol. 2009 May 4;185(3):439-57. (PMID: 19398761)
      Am J Physiol. 1993 Apr;264(4 Pt 2):H1283-91. (PMID: 8476104)
      Science. 2003 Jan 10;299(5604):247-51. (PMID: 12522250)
      Dev Biol. 2008 Jul 15;319(2):309-20. (PMID: 18514180)
      Dev Cell. 2002 Sep;3(3):411-23. (PMID: 12361603)
      Microsc Res Tech. 2001 Oct 15;55(2):122-45. (PMID: 11596157)
      Biochem J. 2009 Apr 15;419(2):261-72. (PMID: 19309313)
      Nature. 1997 Feb 6;385(6616):525-9. (PMID: 9020357)
      Microsc Res Tech. 2001 Oct 15;55(2):70-80. (PMID: 11596152)
      Breast Cancer Res Treat. 2007 Nov;106(1):11-7. (PMID: 17203385)
      J Biol Chem. 2004 Aug 13;279(33):34741-9. (PMID: 15184386)
      Hum Mol Genet. 2003 May 15;12(10):1179-85. (PMID: 12719382)
      Physiol Genomics. 2007 Jan 17;28(2):179-92. (PMID: 17234577)
      Cell Commun Adhes. 2006 Jan-Apr;13(1-2):61-77. (PMID: 16613781)
      Am J Physiol Cell Physiol. 2008 Nov;295(5):C1103-12. (PMID: 18753315)
      Development. 2007 Jan;134(1):199-209. (PMID: 17164425)
      Morfologiia. 2004;126(6):40-2. (PMID: 15839250)
      Hum Genet. 2010 Feb;127(2):231-41. (PMID: 19911200)
      Am J Hum Genet. 2003 Jun;72(6):1470-8. (PMID: 12740761)
      J Physiol. 1992 May;450:503-12. (PMID: 1432715)
      Cold Spring Harb Perspect Biol. 2009 Jul;1(1):a002576. (PMID: 20066080)
      Blood. 2010 May 13;115(19):3997-4005. (PMID: 20110424)
    • Grant Information:
      R01 HL064232 United States HL NHLBI NIH HHS; R01 HL064232-09 United States HL NHLBI NIH HHS; T32 HL007249 United States HL NHLBI NIH HHS; HL64232 United States HL NHLBI NIH HHS
    • Accession Number:
      0 (Connexin 43)
      0 (Connexins)
      0 (Forkhead Transcription Factors)
      0 (GJA1 protein, mouse)
      0 (connexin 47)
      0 (mesenchyme fork head 1 protein)
    • Publication Date:
      Date Created: 20110426 Date Completed: 20110804 Latest Revision: 20231213
    • Publication Date:
      20231215
    • Accession Number:
      PMC3134316
    • Accession Number:
      10.1016/j.ydbio.2011.04.004
    • Accession Number:
      21515254